Showing 261 - 280 results of 318 for search '"Jacobs School of Medicine and Biomedical Sciences"', query time: 0.14s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266

    Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study by Benedict RH, Vo P, Adlard N, Grennan O, Enstone A, Bridge D, Wyn R, Cohan SL

    Published 2024-02-01
    “…Ralph HB Benedict,1 Pamela Vo,2 Nicholas Adlard,2 Olwyn Grennan,3 Ashley Enstone,4 Daisy Bridge,4 Robin Wyn,4 Stanley L Cohan5 1Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Ireland, Dublin, Ireland; 4Adelphi Values PROVE, Bollington, UK; 5Providence Brain and Spine Institute, Providence St. …”
    Get full text
    Article
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274

    A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD by Bazell C, Pollack M, Comellas AP, Sethi S, Alston M, Pyenson B, Hansen D, Caplen M, Staresinic A, Styczynski J, Feigler N

    Published 2022-10-01
    “…Carol Bazell,1 Michael Pollack,2 Alejandro P Comellas,3 Sanjay Sethi,4 Maggie Alston,1 Bruce Pyenson,1 Dane Hansen,1 Melissa Caplen,1 Anthony Staresinic,2 John Styczynski,2 Norbert Feigler2 1Milliman, New York, NY, USA; 2BioPharmaceuticals, US Medical Affairs, AstraZeneca, Wilmington, DE, USA; 3Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA; 4Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USACorrespondence: Michael Pollack, BioPharmaceuticals, US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA, Tel +1 302 886 1253, Email michael.pollack1@astrazeneca.comPurpose: We analyzed population-level administrative claims data for Medicare fee-for-service (FFS) beneficiaries to provide insights on systemic oral corticosteroid (OCS) use patterns and associated health conditions and acute events among patients newly diagnosed with chronic obstructive pulmonary disease (COPD).Background: COPD is a progressive inflammatory disease of the lungs, characterized by acute exacerbations that may lead to increased mortality. …”
    Get full text
    Article
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280